Position
Fidelity in Ocular Therapeutix, Inc
Back to the book · All holders of OCUL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $44.1M$8.47 → $9.82
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 31.8M | $385.9M | — | — | — | 0.0% |
| Q1 2026 | 32.7M | $276.6M | $8.47 | −$116.7M | $7.35M | 0.0% |
| Q2 2026 | 32.8M | $322.5M | $9.82 | $44.1M | $1.87M | 0.0% |